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Knee

Exploring the Pain in Patellofemoral Pain: A
Systematic Review and Meta-Analysis Examining
Signs of Central Sensitization

*Department of Rehabilitation Sciences, University of Wisconsin-Milwaukee; †Department of Health and Human
Performance, Athletic Training Program, Concordia University Wisconsin, Mequon; ‡Department of Physical Therapy,
Marquette University, Milwaukee, WI
Background: Patellofemoral pain (PFP) has high recurrence rates and minimal long-term treatment success. Central
sensitization refers to dysfunctional pain modulation that occurs
when nociceptive neurons become hyperresponsive. Researchers in this area of PFP have been increasingly productive in the
past decade.
Objective: To determine whether evidence supports manifestations of central sensitization in individuals with PFP.
Data Sources: We searched MeSH terms for quantitative
sensory testing (QST) pressure pain thresholds (PPTs),
conditioned pain modulation (CPM), temporal summation,
sensitization, hyperalgesia, and anterior knee pain or PFP in
PubMed, SPORTDiscus, CINAHL, Academic Search Complete,
and EBSCOhost.
Study Selection: Peer-reviewed studies that were written in
English and published between 2005 and 2020 and investigated
QST or pain mapping in a sample with PFP were included in this
review.
Data Extraction: The initial search yielded 140 articles.
After duplicates were removed, 78 abstracts were reviewed. The
full text of 21 studies was examined, and we included 15 studies

in our evaluation: 6 in the meta-analysis, 4 in the systematic
review, and 5 in both the meta-analysis and systematic review.
Data Synthesis: A random-effects meta-analysis was conducted for 4 QST variables (local PPTs, remote PPTs, CPM,
temporal summation). Strong evidence supported lower local
and remote PPTs, impaired CPM, and facilitated temporal
summation in individuals with PFP compared with pain-free
individuals. Evidence for heat and cold pain thresholds was
conflicting. Pain mapping demonstrated expanding pain patterns
associated with long duration of PFP symptoms.
Conclusions: Signs of central sensitization were present in
individuals with PFP, indicating altered pain modulation. The
etiologic and treatment models of PFP should reflect the current
body of evidence regarding central sensitization. Signs of central
sensitization should be monitored clinically, and treatments with
central effects should be considered as part of a multimodal plan
of care.
Key Words:
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Key Points




Pain persistence in patients with patellofemoral pain may be the result of central sensitization.
Individuals with patellofemoral pain demonstrated altered pressure pain thresholds, central pain inhibition, and
central pain facilitation compared with pain-free individuals.
Clinicians should incorporate quantitative sensory tests into the examination process to track improvement over
time.

P

atellofemoral pain (PFP) is a musculoskeletal pain
condition affecting an estimated 25% of the
population and is .2 times more prevalent in
females.1–3 A long duration of symptoms is a consistent
predictor of poor treatment outcomes for individuals with
PFP.4–6 Currently accepted etiologic theory suggests that
pathomechanics of the hip, knee, or foot and ankle lead to
elevated patellofemoral joint loading, which drives nociception and pain.7 Treatment strategies aimed at correcting
observed pathomechanics or reducing patellofemoral joint
loading have led to short-term pain relief; however, pain
persists in .50% of patients at follow ups ranging from 1 to
8 years,8–12 and PFP is recurrent in 70% to 90% of

patients.13 Whereas pathomechanics are one hypothetical
factor in the development of PFP, researchers14 studying
other chronic musculoskeletal conditions have demonstrated the importance of central sensitization in the development of chronic pain.
Central sensitization has been deﬁned by the International Association for the Study of Pain as ‘‘increased
responsiveness of nociceptive neurons in the central
nervous system.’’15 Hallmarks of central sensitization
include pain in the presence of a non-noxious stimulus
(allodynia), pain hypersensitivity at the affected site
(primary hyperalgesia), increased receptive ﬁelds, and pain
hypersensitivity in uninjured tissues beyond the affected
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individuals with PFP, which may guide treatment decisions.
Signs of central sensitization are neglected in current
etiologic or treatment models of PFP. Treatment plans
focusing on strengthening and movement quality alone may
not address a key component contributing to pain
persistence. Therefore, the question guiding this review
was, ‘‘Do individuals with PFP exhibit signs of central
sensitization compared with healthy, pain-free individuals?’’
METHODS
Search Strategy

This systematic review was registered with PROSPERO
(Registration No. CRD42019127548) and was prepared
according to Preferred Reporting Items for Systematic
Reviews and Meta-Analyses (PRISMA) guidelines. We
searched MeSH terms for studies using QST methods and
pain mapping in individuals with PFP in the PubMed,
SPORTDiscus, CINAHL, Academic Search Complete, and
EBSCOhost databases (Supplementary Table). The search
took place between November 2018 and February 2019 and
was repeated in June 2020. Studies were included if they
were published in English in the past 15 years, included at
least 1 QST or pain mapping measure in human
participants, and included a between-subjects (PFP versus
pain-free control) comparison for QST (or cross-sectional
data for pain mapping).
Review Process

One researcher (K.J.S.) conducted the search across
databases and exported all potential studies to EndNote
X8 (Clarivate Analytics) for cross-referencing. The
process of article screening and review is outlined in
Figure 1. Two researchers (K.J.S., J.E.E.B.) independently reviewed titles and abstracts for inclusion. No
conﬂicts needed to be resolved at this stage. Full-text
copies of the included articles were screened. Fifteen
total studies were included, with 11 studies accepted for
the meta-analysis and 9 for the systematic review. Two
reviewers (K.J.S., M.K.H.B.) independently conducted a
quality review using the modiﬁed Downs and Black
checklist.31 The reviewers ﬁrst discussed any scoring
differences, and a plan was in place to have a third
reviewer resolve any disputes. No differences required
third-party resolution.
Data Extraction

We extracted the following information: publication
information (author, year, study design, journal), number
of participants, participant characteristics (age, sex, any
grouping variables and characteristics), and outcome
measures from QST variables (means and SDs or CIs).
When CIs were reported instead of SDs, we converted them
to SDs. Data not presented in the full text of articles or
supplementary data ﬁles were requested from 2 primary
authors, who provided these values or data ﬁles.
Quality Assessment

The modiﬁed Downs and Black checklist was selected for
quality assessment based on the expectation that most
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area (secondary hyperalgesia).16 The presence of central
sensitization is especially important when providing health
care to patients with chronic musculoskeletal pain, as it
may guide treatment selection.17
Quantitative sensory testing (QST) is a test battery for
assessing the state of endogenous pain facilitation and
inhibition.14,18 It has been used to demonstrate altered
somatosensory function in patient populations or subgroups
(eg, those with low back pain, knee osteoarthritis),19,20
predict treatment response,21–24 and guide treatment
selection.16,17,25 Pressure pain thresholds (PPTs), conditioned pain modulation (CPM), temporal summation of
pain, and temperature pain and detection thresholds are all
forms of QST.14,18
Pain thresholds represent the minimum stimulus (pressure, thermal, or electrical) that is perceived as painful.14
Pressure pain thresholds are commonly used QST techniques and involve a mechanical stimulus (eg, pressure
algometer or cuff algometer),14 whereas thermal pain
thresholds involve heat and cold stimuli.26 Lower pain
thresholds at the affected site (eg, the knee) indicate local
pain hypersensitivity and reduced nociceptive thresholds in
the peripheral nervous system. Lower pain thresholds
remote to the affected site (eg, upper limb for a lower
extremity condition) indicate widespread pain hypersensitivity and reduced nociceptive neuron thresholds in the
central nervous system.14,18,27,28
Conditioned pain modulation is the concept that ‘‘pain
inhibits pain’’ and assesses the integrity of central pain
inhibition.14,16,18 During a CPM protocol, pain from a
noxious stimulus (test stimulus) is decreased by a second
noxious stimulus (conditioning stimulus).14,29 If there is
minimal or no change in the perceived pain of the test
stimulus with the conditioning stimulus, CPM is considered
impaired. A reduced CPM response indicates less effective
descending pain inhibition and is a manifestation of central
sensitization.16
Temporal summation of pain assesses the efﬁciency of
central pain facilitation.14 To assess temporal summation,
changes in pain perception over time are recorded during a
sustained or repeated stimulus at a constant noxious
intensity.18 Increased pain reports over time indicate central
sensitization.14 Temporal summation can be measured
using a variety of stimuli, ranging from the application of
heat or cold pain to punctate temporal summation, which
uses a repetitive pinprick test or monoﬁlament application.14,18 Facilitated temporal summation indicates enhanced central pain facilitation.16
Widespread pain is also indicative of dysfunctional
peripheral or central pain modulation.16 Pain maps allow
patients to self-report the pain location and provide
objective measures of the pain area. Spreading of a painful
area beyond the affected body part (ie, the knee) or an
increased number of painful sites may indicate widespread
pain.16,18
In a systematic review, De Oliveira Silva et al30 assessed
the characteristics of pain sensitization in patients with
chronic knee conditions. Moderate evidence supported
hyperalgesia at the knee and upper limb in patients with
PFP, indicating peripheral or central sensitization, respectively. Researchers in this area have been productive
recently, and synthesis of these additional studies may
provide further insight into central changes that occur in

Records identified
through database
searching
n = 138

Additional records
identified through
other sources

n=2

''

Records after duplicates removed
n = 78

Records excluded
n = 34

Full-text articles excluded with reasons

n=6

'Ir

Full-text articles assessed for
eligibility
n = 21

• Protocol published with no results (n = 2)
- - - - ~ • Case report with unclear definition of
patellofemoral pain (n = 1)
• No between-groups (patellofemoral pain
and pain-free) comparison (n = 3)

''

Total studies included
n = 15
• Studies included only in the
meta-analysis (n = 6)
• Studies included only in the
systematic review (n = 4)
• Studies included in both
portions of the review (n = 5)

''

Studies included in the
quantitative synthesis
(meta-analysis)
n = 11
Figure 1. Flowchart of search.

studies would have cross-sectional designs.32 The modiﬁed
Downs and Black checklist has a total of 16 scored items
across 5 categories (reporting, external validity, internal
validity [bias, internal validity], confounding, and pow-

er).32,33 The maximum score is 17, with 15 items scored
from 0 to 1 point, and 1 item scored from 0 to 2 points,
where 0 indicates lower quality and higher numbers
indicate higher quality.
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Records screened
n = 56

Table 1. Description of Criteria of van Tulder et al34
Criterion

Description

Strong

Moderate

Limited
Very limited
Conflicting

Risk of Bias and Publication Bias

Risk of bias was assessed using the Cochrane risk of bias
tool in RevMan 5.0 (Cochrane). Publication bias was
assessed using RevMan 5.0 for homogeneous groups of
studies.
Data Synthesis and Analysis

A random-effects meta-analysis was conducted for QST
variables with 3 studies (local PPTs, remote PPTs, and
CPM) using RevMan 5.0. For all other variables, too few
authors of studies used similar methods to pool data. A
moderator analysis was conducted for local and remote
PPTs. We report the standardized mean differences (SMDs)
with 95% CIs, v2 statistics, s values, I2 values, and results
for the overall effect.
Studies for which meta-analysis was not possible are
described qualitatively using means and SDs or medians
and interquartile ranges when appropriate. Strength of
evidence is described using the criteria of van Tulder et al34
for the levels of evidence, which categorize studies based
on statistical homogeneity (Table 1). Subgroup analyses
were conducted after initial review of the evidence and
when heterogeneity of pooled results was observed.
Moderator analysis was selected because there were too
few studies per outcome variable to properly power a metaregression and allow appropriate interpretation of results.35
RESULTS
Study Characteristics

A total of 15 studies were included in this review: 6 in the
meta-analysis only,37–39,41,42,44 4 in the systematic review
only,45–48 and 5 in both portions of the review.27,28,36,40,43
Eleven evaluated PPTs at the knee,27,28.36–44 10 assessed
PPTs at a remote site, 2 7 , 2 8 , 3 6 – 4 1 , 4 3 , 4 4 5 assessed
CPM,27,36,40,43,44 4 evaluated temporal summation36,40,43,44
3 evaluated heat and cold pain thresholds,43,45,46 and 6 used
pain-mapping techniques.27,28,36,40,47,48 A total of 14
investigations were cross-sectional, and 1 was a cohort
study. For the cohort study,44 only cross-sectional betweengroups baseline data were extracted for data analysis, as the
aim of our review was not to determine treatment effects.
Study and participant characteristics are described in Table
2, and quality scores are provided in Table 3.
890
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Systematic Review

We conducted a systematic review of the data that could
not be pooled because of a low number of total studies or
differences in methods that did not allow for pooled results.
Nine studies were included in the systematic review: 3
assessed thermal pain thresholds,43,45,46 and 6 assessed pain
mapping.27,28,36,40,47,48
Thermal Pain Thresholds. Conﬂicting evidence has
been reported for heat and cold pain thresholds for
participants with PFP.43,45,46 The SMDs could not be
calculated because the data were not normally distributed in
1 study.46 One group43 reported a large effect size (1.2; 95%
CI ¼ 0.8, 1.63), demonstrating lower heat pain thresholds at
the knee in the PFP group than in the pain-free group (n ¼
211), whereas another45 reported no differences between
groups (n ¼ 48).
Pain Mapping. Six high-quality studies27,28,36,40,47,48 (n ¼
583) provided evidence that could not be pooled because of
variations in methods and reporting. Three studies27,28,40
used pain-mapping information to characterize and group
the location of pain into retropatellar, peripatellar, or both,
and total pain-area data were not reported. One group of
researchers36 identiﬁed a higher number of painful sites
with increased symptom duration in the PFP group relative
to a pain-free group. Two studies47,48 demonstrated
increased pain area (pixels) using a digital knee map.
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Data pooled from 3 studies
Minimum of 2 high-quality homogeneous studies
Result may be statistically significant or
nonsignificant
Statistically significant pooled results from multiple
heterogeneous studies
Includes 1 high-quality study or multiple low-quality
homogeneous studies
Statistically heterogeneous results from 1 highquality study or multiple low-quality studies
Results from 1 low-quality study
Pooled results that are nonsignificant
Results derived from multiple statistically
heterogeneous studies, regardless of quality

Strong evidence (n ¼ 983) from 6 high-quality27,28,36,40,43,44 and 5 moderate-quality37–39,41,42 studies
supported a large SMD (0.86; 95% CI ¼ 1.13, 0.59;
Figure 2) that was different in local (knee) PPTs between
individuals with PFP and healthy, pain-free control
individuals. A post hoc subgroup analysis was conducted
to explore the effect of sex (female-only studies versus
mixed-sex studies) on local PPTs. Subgroup analysis
demonstrated maintained heterogeneity (I2 ¼ 73% and
16%, respectively; Figure 2) and differences (P  .001 for
each subgroup).
Strong evidence (n ¼ 946) from 6 high-quality27,28,36,40,43,44 and 4 moderate-quality37–39,41 studies was
observed for a moderate SMD that was different in remote
(upper limb) PPTs between individuals with PFP and the
healthy, pain-free control group (SMD ¼ 0.72 [0.97,
0.47]; Figure 3). We conducted a post hoc subgroup
analysis to explore the effect of sex on remote PPTs. This
analysis demonstrated maintained heterogeneity in mixedsex (I2 ¼ 41%) and female-only (I2 ¼ 51%) cohorts and
differences (P , .001 for mixed-sex and female-only
studies).
Strong evidence (n ¼ 554) from 5 high-quality studies27,36,40,43,44 supported a small SMD (0.42 [0.61,
0.24]; P , .001) that was different for the CPM response
between individuals with PFP and healthy, pain-free control
individuals (Figure 4). Subgroup analysis (for sex or other
variables) was not conducted for CPM, as no heterogeneity
was present (I2 ¼ 0%).
Strong evidence (n ¼ 492) from 4 high-quality studies27,36,43,44 supported a moderate SMD (0.69 [0.48, 0.90])
that was different for the temporal summation responses
between those with PFP and pain-free control individuals
(Figure 5). Subgroup analysis was not conducted for CPM,
as no heterogeneity existed (I2 ¼ 0%).

Table 2. Study Characteristics Extended on Next Page
PFP Symptom Duration,
mo, Mean 6 SD
or Median (IQR)

Boudreau et al47 (2017)

35 with PFP (18.8 6 1.7):
2 males, 33 females

60 6 33

NR

Boudreau et al48 (2018)

299 with PFP: 126 males
(23.1 6 8.2), 173
females (19.1 6 8.2)

24 (12–48)

NR

Holden et al36 (2018)

65 females: 36 with PFP
(22.8 6 1.1), 29 CON
(23.1 6 1.2)

96 (84–120)

KOOS-Symptoms: 71 6 16;
KOOS-Pain: 67 6 13;
KOOS-ADL: 78 6 13;
KOOS-Sport and Recreation: 48 6 21;
KOOS-Quality of Life: 51 6 21

Holden et al44 (2020)

201 total: 151 with PFP
(36 males, 115 females;
12 6 1.2), 50 pain-free
(19 males, 31 females;
12.3 6 1.4)
48 total: 25 with unilateral
PFP (9 males, 16
females; 32 [19–44]), 23
healthy (11 males, 12
females; 29 [18–44])
114 total: 91 with unilateral
PFP (56 males, 35
females; 31.2), 23
healthy (11 males, 12
females; 29)
211 total: 150 with PFP
(53 males, 97 females;
32.1), 61 CON (24
males, 37 females; 32.6)

Study

Jensen et al45 (2007)

Jensen et al46 (2008)

Maclachlan et al43 (2020)

Noehren et al37 (2016)

Pazzinatto et al38 (2016)

Pazzinatto et al39 (2017)

Rathleff et al28 (2013)

40 females: 20 with PFP
(23.2 6 5.6), 20 CON
(22.7 6 5.0)
71 female runners: 38 with
PFP (21.6 6 2.6), 33
asymptomatic CON
(22.4 6 3.5)
40 female runners: 20 with
PFP (25.62 6 4.05), 20
asymptomatic CON (27
6 5.58)

79 female adolescents: 57
with PFP (17.13 6 1.1),
22 CON (17.1 6 0.9)

18 (9–24)

Patient-Reported
Outcome Score,
Mean 6 SD or Median

74 (12–260)

KOOS-Symptoms: 78.2 6 12.2;
KOOS-Pain: 68.5 6 1.2;
KOOS-ADL: 79 6 14.3;
KOOS-Sport and Recreation: 55.3 6 21.2;
KOOS-Quality of Life: 49.3 6 15.5
NR

70 (3–240)

Cincinnati Rating Scale: 66

,6: 7.4%;
6–12: 3.3%;
13–60: 37.3%;
60–120: 20.7%;
.120: 31.3%

40.8 6 52.8

AKPS: 72.5 6 12;
KOOS-Symptoms: 78.4 6 12.5;
KOOS-Pain: 75.8 6 12.9;
KOOS-ADL: 85.7 6 13.5;
KOOS-Sport and Recreation: 65.8 6 19.7;
KOOS-Quality of Life: 51.9 6 20.5;
KOOS-PF: 61.8 6 17.9
NR

62.3 6 46.1

NR

37.7 6 49.3

AKPS: 80.45

34 (18–51)

KOOS-Symptoms: 97.7 6 3;
KOOS-Pain: 99.7 6 1.2;
KOOS-ADL: 99.9 6 0.3;
KOOS-Sport and Recreation: 99.5 6 1.5;
KOOS-Quality of Life: 99.1 6 2.1
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Participants,
No. (age, y, mean 6 SD
or median [IQR])

Table 2. Extended From Previous Page
Physical
Activity
Level

Body Mass
Index, Mean

Pain Intensity,
Mean 6 SD
or Median (IQR)a

Type of QST

Summary of Findings

NR

VAS current: 4.8 6
2.7

PM

NR

NR

VAS worst: 5.0
(3.3–7.0)

PM

PFP group: 24.1;
CON group: 22.7

NR

NRS current: 2.0 6
2.0;
NRS worst previous
4 wk: 7.0 6 2.0;
NRS average
previous 4 wk:
4.0 6 1.0

PPTs, TSP,
CPM, PM

NR

NR

NRS worst previous
wk: 6.6 6 2.2

PPTs, CPM,
TSP

PFP group: 23.8;
CON group: 23.4

NR

HPT, CPT

HPT: PFP group ¼ CON group.
CPT: PFP group ¼ CON group.

PFP group: 23.4;
CON group: 23.1

NR

VAS current: 2.4
(SD NR);
VAS worst: 5.5 (SD
NR)
NR

HPT, CPT

HPT: PFP group ¼ CON group.
CPT: PFP group ¼ CON group.
Other: 32% of participants with PFP did not achieve CPT
before cold limit (18C). 15 With PFP reported heat
sensation with CPT testing.

PFP group: 25.2;
CON group: 24.0

Weekly activity
level (IPAQ):
PFP group,
4849.2; CON
group, 3191.7

VAS worst: 5.4 6
1.6

PPTs, TSP,
CPM,
HPT, CPT

Local PPTs: PFP group , CON group (center of patella).
Remote PPTs: PFP group , CON group (elbow).
TSP: PFP group . CON group (pinprick test).
CPM: PFP group ¼ CON group (cold pressor test).
HPT: PFP group , CON group.
CPT: PFP group , CON group.

NR

NR

NRS current: 5.8 6
2.0

PPTs

Local PPTs: PFP group , CON group (patellar tendon).
Remote PPTs: PFP group , CON group (elbow).

NR

NR

NR

PPTs

Local PPTs: PFP group , CON group (lateral to the
patella).
Remote PPTs: PFP group , CON group (elbow).

NR

Distance run per
week: PFP
group, 19.75
km; CON
group, 20.75
km
NR

VAS current: 1.2 6
1.5;
VAS worst previous
mo: 4.8 6 1.5

PPTs

Local PPTs: PFP group , CON group (center of patella).
Remote PPTs: PFP group , CON group (elbow).

VAS worst: 5.0
(3.8–6.8);
VAS current: 1.3
(0.3–2.7)

PPTs, PM

Local PPTs: PFP group , CON group (center of patella).
Remote PPTs: PFP group , CON group (tibialis
anterior).
PM: Majority of PFP group reported bilateral pain that
was peripatellar and diffuse.

PFP group: 20.5;
CON group: 21.4
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PM: Most patients reported peripatellar pain, less than
half reported combined retropatellar and peripatellar
pain, and 1 reported retropatellar pain.
Patients with symptoms .5 y demonstrated larger pain
area than did those with symptoms of ,5 y.
Most patients reported symmetric bilateral pain.
Longer symptom duration was related to spreading of
pain up the thigh and down the leg.
PM: No sex differences in pain clusters or distributions.
Longer symptom duration was associated with bilateral
PFP.
Longer symptom durations were related to larger pain
area and specific pain patterns, including pain up the
thigh and down the lower leg.
Pain intensity was not related to pain area.
Local PPTs: PFP group , CON group (center of patella).
Remote PPT: PFP group , CON group (elbow).
TSP: PFP group . CON group (cuff algometry).
CPM: PFP group ¼ CON group (cuff algometry).
PM: Most of PFP group reported pain in an area in
addition to the knee, and 21% of PFP group met
American College of Rheumatology criteria for
widespread pain.
Local PPTs: PFP group , CON group (center of patella).
Remote PPTs: PFP group , CON group (elbow).
CPM: PFP group , CON group (cuff algometry).
TSP: PFP group . CON group (cuff algometry).
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NR

Table 2. Continued From Previous Page

Study

Participants,
No. (age, y, mean 6 SD
or median [IQR])

PFP Symptom Duration,
mo, Mean 6 SD
or Median (IQR)

Patient-Reported
Outcome Score,
Mean 6 SD or Median

40 females: 20 with PFP
(20 [19–21]), 20 CON
(20.5 [20–21])

72 (4.5–7)

KOOS-Symptoms: 96 6 5;
KOOS-Pain: 99 6 2;
KOOS-ADL: 100 6 1;
KOOS-Sport and Recreation: 98 6 3;
KOOS-Quality of Life: 97 6 7

Rathleff et al27 (2017)

65 total: 33 with PFP (10
males, 23 females; 28.5
6 5.3), 32 CON (10
males, 23 females; 27.1
6 5.2)

24 (14–60)

NR

van der Heijden et al42 (2015)

38 (12 males, 26 females):
22 with PFP (22 6 5.8),
16 CON (22.5 6 6.5)

12 6 6.5

NR

van der Heijden et al41 (2018)

134 adults and
adolescents (60 males,
74 females): 64 with
PFP (35 female, 29
males; 44 adults, 20
adolescents; 23.4 6 7),
70 CON (41 females, 29
males; 50 adults, 20
adolescents; 23.1 6
5.9)

Adults: 11 6 6.4;
Adolescents: 14.2 6 8.1;
Females: 13.7 6 6.8;
Males: 9.9 6 7.1

AKPS: 66.3 6 11.6

Abbreviations: AKPS, Anterior Knee Pain Scale; CON, control; CPM, conditioned pain modulation; CPT, cold pain threshold; HPT, heat pain
threshold; IPAQ, International Physical Activity Questionnaire; IQR, Interquartile range; KOOS, Knee Osteoarthritis Outcome Score; NR, not
reported; NRS, numeric rating scale; PF, Patellofemoral subscale; PFP, patellofemoral pain; PM, pain mapping; PPT, pressure pain
thresholds; QST, quantitative sensory testing; TSP, temporal summation of pain; VAS, visual analog scale.
a
Pain intensity was measured on either a 10-cm VAS or an NRS with a maximum score of 10.

Distinct pain patterns associated with spreading of pain up
the thigh and down the lower leg were also associated with
longer symptom durations. These ﬁndings lend support for
central sensitization but warrant further examination.
Risk of Bias and Publication Bias. The risk-of-bias
assessment indicated that allocation concealment and
adequate expression of group differences may be threats
to study validity (Table 4). Only 3 investigations27,36,40
concealed group allocation from the researcher, which
could have introduced researcher bias. Unpublished work in
this area was not sought. This may have led to an increased
risk of publication bias, regardless of our ﬁndings. A funnel
plot for published studies of CPM (Figure 6) showed some
asymmetry, likely due to the low number of studies (k ¼
5)27,36,40,43,44 and small sample sizes in each study. A funnel
plot for temporal summation produced a nearly vertical line
with most results on the sensitized portion of the graph,
indicating the likelihood that studies with results that were
different may be published more frequently (Figure 7). This
bias is difﬁcult to conﬁrm with no data from unpublished
studies, a low number of studies (k ¼ 4),36,40,43,44 and small
sample sizes. We could not assess publication bias for PPTs
because of the heterogeneity observed in all meta-analysis
results.35

DISCUSSION

The purpose of our review was to determine whether the
current literature supports central sensitization in individuals with PFP compared with pain-free control individuals.
Our ﬁndings supplied strong support for signs of central
sensitization, including lower local and remote PPTs,
impaired CPM, and facilitated temporal summation in
those with PFP. The evidence was conﬂicting regarding
altered heat and cold pain thresholds in individuals with
PFP. Signs of central sensitization demonstrated ineffective
pain modulation in the central nervous system. Although
muscle weakness and altered biomechanics may be key
components of PFP development, they may not be the only
sources of pain persistence. Signs of central sensitization
should be monitored clinically, and treatments with central
effects should be considered part of a multimodal plan of
care.
Potential Mechanisms of Central Sensitization in
Patients With PFP

The cause of PFP is hypothesized to be pathomechanical.
Motor and biomechanical dysfunction of the hip, knee, and
foot or ankle have been proposed to lead to increased
patellofemoral joint loading.7 Treatments that align with
this theory include movement retraining, hip and thigh
Journal of Athletic Training
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Rathleff et al40 (2016)

Table 2. Continued From Previous Page
Physical
Activity
Level

Body Mass
Index, Mean

Pain Intensity,
Mean 6 SD
or Median (IQR)a

Type of QST

Sport
participation:
PFP group,
80%; CON
group, 75%

NR

PPTs, TSP,
CPM, PM

PFP group: 24.2;
CON group: 21.9

NR

NRS worst previous
wk: 5.0 (3.0–7.0)

PPTs, CPM,
PM

PFP group: 23.9;
CON group: 23.3

Sport
participation:
PFP group,
54.5%; CON
group, 81.3%
Sport
participation:
PFP group,
38%; CON
group, 55%

NRS current: 4.7 6
2.3

PPTs

NRS current: 4.7
(SD NR)

PPT

PFP group: 23.6;
CON group: 22.3

strengthening, and use of corrective orthoses. Despite the
efﬁcacy of these treatments, PFP has high rates of
recurrence9,12,49,50 and persistence.13 With a centrally
sensitized nervous system, a pain response to subsequent
patellofemoral joint loading may reﬂect the functional state
of central neurons16 rather than the state of the kinetic chain
and patellofemoral joint loading. This means that clinicians
may treat the underlying movement factors but still neglect
a key mechanism of pain persistence. Treating a patient
with signs of central sensitization requires a multimodal
treatment plan that affects central pain-modulation mechanisms.17 Clinicians would best serve patients with PFP by
Table 3. Quality Review Based on Modified Downs and Black
Scores33
Study
47

Boudreau et al (2017)
Boudreau et al48 (2018)
Holden et al36 (2018)
Holden et al44 (2020)
Jensen et al45 (2007)
Jensen et al46 (2008)
Maclachlan et al43 (2020)
Noehren et al37 (2016)
Pazzinatto et al38 (2016)
Pazzinatto et al39 (2017)
Rathleff et al28 (2013)
Rathleff et al40 (2016)
Rathleff et al27 (2017)
van der Heijden et al42 (2015)
van der Heijden et al41 (2018)
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Score (No./17)

Quality

13
14
14
16
9
8
14
12
12
10
13
13
15
10
12

High
High
High
High
Low
Low
High
Moderate
Moderate
Moderate
High
High
High
Moderate
Moderate
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Summary of Findings
Local PPTs: PFP group , CON group (center of patella).
Remote PPTs: PFP group , CON group (elbow).
TSP: PFP group ¼ CON group (cuff algometry).
CPM: PFP group , CON group (cuff algometry).
PM: Most participants with PFP reported peripatellar pain
that included spreading pain up the thigh.
Local PPTs: No difference between PFP and CON
groups (center of patella).
Remote PPTs: No difference between PFP and CON
groups (elbow).
CPM: PFP ¼ CON group (cold-pressor test).
PM: Most participants with PFP reported retropatellar
pain and combined retropatellar and peripatellar pain.
One reported only peripatellar pain.
Local PPTs: PFP group , CON group (center of patella).

Local PPTs: PFP group , CON group (most painful
location).
Remote PPTs: PFP group , CON group (forearm).
Other: age did not affect PPTs.
Lower PPTs for females versus males for bilateral knees
and the contralateral arm. Sex modified effect size
between PFP and CON groups.

obtaining and tracking signs of sensitization to monitor
progress.17
Participant Characteristics

Several interpersonal factors can affect central sensitization and pain perceptions.43,51 Subjective clinical measures
of pain intensity, age, sex, body mass index, physical
activity level, perceptions of knee function, and symptom
duration may play roles in QST responses. A breakdown of
consistently reported participant characteristics is given in
Table 2.
Symptom duration had a wide range (3.4 months to .10
years); however, authors of 13 of the 15 studies included in
the review noted mean or median symptom durations of 18
months or longer.27,28,36–40,43–48 Physical activity level was
described in different units (mean weekly metabolic
minutes of physical activity, kilometers of running per
week, and percentage of sport participation) in 5 studies.39–43 The PFP groups reported more metabolic minutes
than did the pain-free groups,43 PFP and healthy groups
reported similar weekly running distances,39 and comparisons of sport participation varied by study.40,41,42 In 1
study,43 49% of the PFP group (PFP group: n ¼ 150)
indicated they stopped normal activity because of their
knee pain. Body mass index was provided in 8 studies27,28,36,41–43,45,46 and was higher in the PFP group in only
1 study.41 Six investigations assessed females only,28,36–40 9
assessed mixed-sex cohorts,27,41–48 and none assessed males
only.
Measures of function and pain intensity were more
commonly collected (Table 2). Whereas speciﬁc scores on
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NR

PFP
group

Study or subgroup

Standardized
mean
difference

Mixed sex
Holden et al44 (2020)
van der Heijden et al 41 (2018)
Maclachlan et al43 (2020)
van der Heijden et al 42 (2015)
Rathleff et al 27 (2017)

-1.0535
-0.8053
-0.5641
-0.1401
-0.0427

SE

0.1764
0.18
0.1544
0.329
0.2481

Subtotal (95% Cl)

Total,
No.

Painfree
group

Total,
No.

Weight,

%

Standardized
mean difference
inverse variance,
random (95% Cl}

Standardized
mean difference inverse
variance, random (95% Cl)

150
64
150
22
33

50
70
61
16
32

11.2
11.1
11.7
7.6
9.5

-1.05
-0.81
-0.56
-0.14
-0 04

(-1 .40, -0.71)
(-1.16, -0.45)
(-0.87, -0.26)
(-0.78, 0.50)
(-0.53, 0.44)

419

229

51.0

-0.57 (-0.91, -0.23)

20
57
38
36
20
20

20
22
33
29
20
20

6.9
8.8
9.1
8.8
7.6
7.7

191

144

49.0

-1.18 (-1.45, -0.92)

610

373

100.0

-0.86 (-1.13, -0.59)

Heterogeneity: r 2 = 0.11; xi = 14.68; P = .005; 12 = 73%

Female only
Pazzinatto et al 39 (2017)
Rathleff et al 28 (2013)
Pazzinatto et al 38 (2016)
Holden et al 36 (2018)
Noehren et al 37 (2016)
Rathleff et a1•0 (2016)

-1.5821
-1 .3961
-1.2919
-1.2676
-0.8483
-0 .6291

0.367
0.2756
0.2628
0.2746
0.3315
0.3248

Subtotal (95% Cl)

-1.58
-1.40
-1.29
-1.27
-0.85
-0.63

(-2.30,
(-1.94,
(-1.81,
(-1.81,
(-1.50,
(-1.27,

-0.86)
-0.86)
-0.78)
-0.73)
-0.20)
0.01)

•

Heterogeneity: r 2 = 0.02; x~ = 5.97; P = .3 1; 12 = 16%
Test for overall effect: Z = 8.80; P < .001
Total (95% Cl}
Heterogeneity:

T2

= 0.14; Xfo = 33.49; P < .001 ;

12

-2

•

-1
Sensitized

= 70%

Test for overall effect: Z = 6.3 1; P < .001

0

2
Not sensitized

Test for subgroup differences: xf = 7.66; P = .006; 12 = 86.9%

Figure 2. Meta-analysis results of local pressure pain thresholds.

the Knee Osteoarthritis Outcome Score and Anterior Knee
Pain Scale are not indicative of categorical function or
ability, scores closer to 0 represent greater problems, and a
score of 100 indicates no problems. The range of scores for
the included studies was 63 to 100, which may suggest a
moderate to low level of disability. Little evidence to date
aligns relationships between central sensitization and
perceptions of function. Researchers in 12 studies27,28,36,37,39,41–45,47,48 reported pain intensity at the time
of the study (current), worst pain, or pain in the past week
or month using numeric rating scales or visual analog
scales.
Patellofemoral pain is a condition affecting a wide age
range, from adolescents to older adults.52 Only 2 studies28,44
involved participants with a mean age of ,18 years; the
mean age of participants was .25 years in 5 studies.27,39,43,45,46 Some authors50,52 have contended that PFP
may be a different experience for adolescents than adults
and that onset in adolescence may result in persistence or
recurrence in adulthood. The effect of age on QST results
should continue to be explored among individuals with
PFP.
Pressure and Thermal Pain Thresholds

Strong evidence supported reduced local and remote
PPTs in individuals with PFP. Nine of the included studies
assessed pressure algometry,27,28,36–40,43,44 and 2 studies
assessed a handheld dynamometer method.41,42 We observed group differences in all but 1 investigation,27 and it

a

Abbreviation: PFP, patellofemoral pain.

may be worth noting that the mean age was older than that
reported in most investigations (28.5 years). Based on our
subgroup analyses, both female-only and mixed-sex studies
maintained statistical heterogeneity. Sex should still be
considered during analysis, as females experienced a
variety of PFP symptoms and factors differently than did
males,36,40,53,54 but sex alone may not be enough to explain
the observed differences in PPTs.
When considered alone, lower local (knee) PPTs are
manifestations of peripheral sensitization; however, when
considered concurrently with reduced remote PPTs, they
indicate central excitability.16,55 Some authors55 have
proposed a mechanism by which local joint nociceptors
may maintain central sensitization. This hypothesis offers
potential explanations for ﬁndings of local and widespread
hyperalgesia in patients with chronic musculoskeletal
conditions.55 The authors postulated that peripheral sensitization spreads to extraterritorial regions by stimulating
adjacent neurons in the dorsal horn of the spinal cord. Other
researchers16,18 have supported the idea that if the central
nervous system is sensitized, peripheral nociceptors will
also demonstrate increased excitability due to dysfunctional
descending pain modulation. Without longitudinal evidence, it is impossible to make the distinction. Regardless
of the mechanism, clinical manifestations of PFP include
local and remote hyperalgesia. Assessing and tracking PPTs
using a handheld pressure algometer (a quick, inexpensive,
and easy-to-learn option for clinicians) would help
clinicians monitor progress by providing an objective
measure of pain hypersensitivity.
Journal of Athletic Training
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Test for overall effect: Z = 3.25; P = .001

PFP
group

Study or subgroup

Standardized
mean
difference

Mixed sex
Holden et al44 (2020)
Maclachlan et al 43 (2020)
van der Heijden et al 41 (2018)
Rathleff et al 27 (2017)

-0.7202
-0.5122
-0.3958
-0.0375

SE

Total,
No.

0.1873
0.1539
0.1747
0.2481

Subtotal (95% Cl)

Painfree
group

Weight,

Total,
No.

%

Standardized
mean difference
inverse variance,
random (95% Cl)

151
150
64
33

50
61
70
32

12.2
13.3
12.6
10.2

-0.72 (-1.09,
-0.51 (-0.81,
-0.40 (-0.74,
-0.04 (-0.52,

398

213

48.2

-0.45 (-0.69, -0.21)

20
20
38
57
20
36

20
20
33
22
20
29

6.7
7.5
9.9
9.7
8.0
10.0

-1.78 (-2.52,
-1.18 (-1.86,
-1.10 (-1.60,
-0.98 (-1.49,
-0.57 (-1.21,
-0.49 (-0.99,

191

144

51.8

-0.98 (-1.31, -0.64)

589

357

100.0

-0.72 (-0.97, -0.47)

Standardized
mean difference inverse
variance, random (95% Cl)

-0.35)
-0.21)
-0.05)
0.45)

•

=0.02; x~ =5.08; P =.17; 12 =41 %
Test for overall effect: Z =3.72; P < .001
Heterogeneity: r 2

-1.7769
-1.1823
-1.0951
-0.9785
-0.5742
-0.4942

0.3792
0.3455
0.256
0.2634
0.3234
0.2535

Subtotal (95% Cl)

-1.03)
-0.51)
-0.59)
-0.46)
0.06)
0.00)

....

=0.09; x~ =10.12; P =.07; 12 =51%
Test for overall effect: Z =5.65; P < .001
Heterogeneity: r 2

Total (95% Cl)

=

=

=

Heterogeneity: r 2 0.1 0; x~ 25.36; P .003;
Test for overall effect: Z 5.60; P < .001

=

Test for subgroup differences:

12

-2

=65%

•

-1

0

Sensitized

2
Not sensitized

xf =6.19; P =.01; 12 =83.8%

Figure 3. Meta-analysis results of remote pressure pain thresholds.

a

Three studies43,45,46 assessed thermal pain thresholds, but
we could not pool those data. Two groups45,46 reported no
differences between heat and cold pain thresholds between
groups, whereas 1 group43 observed lower thresholds for
both modalities in the individuals with PFP. Remote
assessment was also conducted at the elbow in 1
investigation43 and demonstrated lower thresholds for both
(heat and cold) modalities in the patients with PFP. Jensen
et al46 noted that 32% of participants with PFP did not
achieve cold pain thresholds before reaching the maximum
temperature limit. Whereas we could not include these data
in the ﬁnal analysis, increased cold pain thresholds may be
inferred due to the lower temperatures that would have been

needed to sense pain.46 This ﬁnding may also be a sign of
hypoesthesia, or loss of sensation, which can manifest
because of dysfunctional peripheral or central pain
modulation.
Researchers37,45,46 have hypothesized that nociception
may be prioritized over touch and temperature information
in individuals with PFP. Hypoesthesia, or impaired tactile
sensation, was seen in 3 studies37,45,46 and increased
vibration thresholds in 1 study,46 supporting this notion.
When assessed concurrently with central sensitization,
these data may support inhibition of non-noxious sensory
information while nociceptive neurons are activated to
subthreshold levels. Further examination is needed to better

PFP
group

Study or subgroup

Standardized
mean
difference

Rathleff et al 40 (2016)
Holden et al 44 (2020)
Maclachlan et al 43 (2020)
Holden et al 36 (2018)
Rathleff et al 27 (2017)

-0.7594
-0.5518
-0.402
-0.39
-0.0947

SE

Total,
No.

0.3286
0.1856
0.1531
0.2562
0.2482

Total (95% Cl)

Abbreviation: PFP, patellofemoral pain.

Painfree
group

Total,
No.

Weight,

%

20
138
150
35
33

20
38
61
27
32

8.2
25.8
37.9
13.6
14.4

376

178

100.0

Standardized
mean difference
inverse variance,
random (95% Cl)

-0.76
-0.55
-0.40
-0.39
-0.09

(-1.40,
(-0.92,
(-0.70,
(-0.89,
(-0.58,

Standardized
mean difference inverse
variance, random (95% Cl)

-0.12)
-0.19)
-0.10)
0.11)
0.39)

-0.42 (-0.61, -0.24)
I

=

=

=

Heterogeneity: r 2 0.00; x~ 3.31; P .51; 12
Test for overall effect: Z = 4.50; P < .001

Figure 4. Meta-analysis results of conditioned pain modulation.
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Female only
Noehren et al 37 (2016)
Pazzinatto et al 38 (2016)
Pazzinatto et al 39 (2017)
Rathleff et al 28 (2013)
Rathleff et al 40 (2016)
Holden et al 36 (2018)

PFP
group

Study or subgroup

Standardized
mean
difference

Maclachlan et al 43 (2020)
Holden et al 44 (2020)
Holden et al 36 (2018)
Rathleff et al 40 (2016)

0.5911
0.773
0.8
0.9

SE
0.1546
0.1879
0.28
0.71428

Total (95% Cl)

Total,
No.

Painfree
group

Total,
No.

Weight,
%

150
138
36
20

61
38
29
20

49.3
33.4
15.0
2.3

344

148

100.0

Standardized
mean difference
inverse variance,
random (95% Cl)
0.59
0.77
0.80
0.90

Standardized
mean difference inverse
variance, random (95% Cl)

(0.29, 0.89)
(0.40, 1.14)
(0.25, 1.35)
(-0.50, 2.30)

0.69 (0.48, 0.90)
I

I

-1
-2
Not sensitized

Heterogeneity: 1 2 = 0.00; x~ = 0.85; P = .84; 12 = 0%
Test for overall effect: Z = 6.36; P < .001

understand the role of thermal pain ﬁndings in this
population.
Conditioned Pain Modulation

A key ﬁnding in this review was strong support for
impaired CPM in individuals with PFP relative to pain-free
individuals.36,40,43,44 Impaired CPM represents inefﬁcient
central pain inhibition.14 The CPM paradigms can be
assessed using a variety of protocols.29 Three studies
included in this review used cuff algometry,36,40,44 and 2
studies assessed the cold-pressor test.27,43 Authors of 240,44
of the 3 studies that used cuff algometry reported impaired
CPM in the PFP group, whereas neither of the 2 studies27,43
that used the cold-pressor test demonstrated inefﬁcient
CPM in the PFP group. This could indicate that the type of
conditioning stimulus affects the results even if the
measurement unit (pressure in kilopascals) is the same. In
addition, the pooled data did not reﬂect any heterogeneity,
and both investigations that used the cold-pressor test
involved mixed-sex cohorts, whereas 236,40 of the 3 studies
assessing cuff algometry involved only females. The SMD
was small but different for impaired CPM between groups,
and 327,43,44 of 5 studies involved mixed-sex samples. We
recommend that sex should continue to be considered a

a

2
Sensitized

Abbreviation: PFP, patellofemoral pain.

subgrouping variable in order to better understand whether
sex differences exist.
The CPM responses exist on a continuum and are
associated with wide interpersonal differences.14 For this
reason, identifying and tracking within-patient CPM
responses can test and ensure restoration of efﬁcient central
pain modulation pathways. In other chronic musculoskeletal pain conditions, impaired CPM has been hypothesized
to affect a subgroup of the overall patient population, and
the same should be expected in PFP. 14,18 Clinical
assessment of CPM would be useful for determining
individual responses and can be used to monitor descending
central pain modulation.
Temporal Summation of Pain

Another key ﬁnding from this review was strong
evidence36,40,43,44 for enhanced temporal summation in
individuals with PFP. Enhanced temporal summation
represents increased central pain facilitation. Three groups
of researchers36,40,44 used cuff algometry, and 1 group43
used the pinprick test to assess temporal summation. Two
sets of authors36,40 included only females with PFP, and 2
sets of authors43,44 included both males and females. All
studies36,40,43,44 examined individuals with longstanding
PFP symptoms (range ¼ 4.5 months to .10 years).

Table 4. Risk of Biasa

Study
Boudreau et al47 (2017)
Boudreau et al48 (2018)
Holden et al36 (2018)
Holden et al44 (2020)
Jensen et al45 (2007)
Jensen et al46 (2008)
Maclachlan et al43 (2020)
Noehren et al37 (2016)
Pazzinatto et al38 (2016)
Pazzinatto et al39 (2017)
Rathleff et al28 (2013)
Rathleff et al40 (2016)
Rathleff et al27 (2017)
van der Heijden et al42 (2015)
van der Heijden et al41 (2018)

Clear
Purpose
and Aim?

Allocation
Concealed?

Unreported or Loss
of Participant Data
(.2 cases)

Group Differences Reported
(Mean 6 SD or 95% CI)

þ
þ
þ
þ
þ
þ
þ
þ
þ
þ
þ
þ
þ
þ
þ

NS
NS
þ
NS


NS




þ
þ



þ

þ
þ

þ
þ
þ



þ

þ
þ

þ
þ
þ
þ
þ
þ
þ
þ
þ
þ
þ
þ

þ
þ

Abbreviation: NS, not specified.
a
þ Indicates no risk of bias and  indicates risk of bias in this category.
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Figure 5. Meta-analysis results of remote temporal summation of pain.
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Figure 6. Funnel plot of results from published conditioned pain
modulation studies.

Figure 7. Funnel plot of results from published temporal summation of pain studies.

Analyses of temporal summation responses differed
across studies, which may have resulted in different
outcomes. Rathleff et al40 used normalized visual analog
scale scores from each of the 10 consecutive test intervals,
Holden et al36 assessed the difference in visual analog scale
averages from the last 3 intervals and the second through
fourth intervals, and Maclachlan et al43 measured the
maximum possible effect as a percentage between the ﬁrst
and worst numeric rating scale. Interestingly, Holden et al36
also observed a lower temporal summation response for
individuals who had recovered from PFP compared with
those who were currently symptomatic. Both PFP groups
reported enhanced pain facilitation relative to the pain-free
group.36 Temporal summation responses may be restored
among patients with PFP, supporting the clinical relevance
of these ﬁndings.17

especially if the original pain was unilateral.56 In the data
presented, whether the original onset of pain was bilateral,
mirror image, or unilateral was not indicated, but this
aspect would be an interesting addition to the pain-mapping
research in patients with PFP.
Although pain maps limited to the knee can provide
useful information on localized pain, widespread pain may
be better portrayed on bilateral lower extremity or wholebody maps. To improve our understanding of the effect that
expanding pain areas have on individuals with PFP,
consistency in analyzing and reporting these data is
important. Pain spreading beyond the knee and mirrorimage bilateral pain offer support for central sensitization.

Pain Mapping

Pain mapping can provide evidence of widespread pain.
Unfortunately, only 2 pain-mapping studies47,48 involved
the same methods or reported outcomes, making an
analysis of pooled information difﬁcult. Five27,28,40,47,48 of
the 6 studies27,28,36,40,47,48 in this area only assessed a knee
pain map, which differed among investigations, and 136
assessed pain maps for a number of painful sites. Other
painful locations were the hip, pelvis, back, and neck.36,47,48
However, we were able to determine from the existing
evidence that individuals with PFP may have an increased
pain area or number of painful sites as symptoms persist
over time.27,28,36,47,48 In fact, Boudreau et al47,48 suggested
that speciﬁc pain patterns may extend beyond the knee with
increased symptom duration. The observed patterns represented a broader pain area around the knee in addition to
pain spreading up the thigh and down the lower leg.47,48
These results are supported by Rathleff et al,28 who noted
that diffuse pain was experienced by 54% of the sample,
regional pain by 30%, and local pain by only 16%. Bilateral
PFP28,47,48 was more common than unilateral PFP. Bilateral
PFP was also associated with longer symptom durations
(median ¼ 24 months; interquartile range ¼ 12–60 months),
and patients with bilateral pain described mirror-image pain
in 56% of cases.48 Both neural and immune factors have
been hypothesized to cause mirror-image pain patterns, and
this ﬁnding is commonly attributed to central sensitization,
898
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Risk of Bias and Publication Bias

Our assessment of the risk of bias suggested that more
studies in which group allocation is concealed from the
researcher are needed. We could not properly evaluate
publication bias because of the lack of homogeneity in
results and a lack of data regarding unpublished or
prepublication studies. This information may be useful in
drawing meaningful conclusions and extrapolating the
results of this review to the population with PFP.
Clinical Relevance

Although exploration of treatment effects was beyond the
scope of our review, central pain modulation has been
effectively restored using interventions with known central
effects. These treatment options include transcutaneous
electrical nerve stimulation, manual therapy, pain education, and exercise therapy. Thus far, few researchers have
explored the effectiveness of these interventions in patients
with PFP. Given the hypothesized pathomechanical cause
of the condition, it is necessary to determine whether
central sensitization has any effect on or relation to
observed movement or motor dysfunction. Without that
information, a multimodal patient-centered treatment
approach may offer the best opportunity for long-term
symptom relief. If restoration of central pain modulation,
pain control, or coping can occur, then movement retraining
and exercise therapy may be more effective than using any
of the aforementioned interventions alone.
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Limitations

The main limitations of this review were the small
number of studies for each QST variable and population
differences among them. As discussed, personal factors (ie,
age, sex, activity level) may play a role in pain perceptions
during QST assessment. We were unable to identify the
role of potential subgroups because of limited consistency
in reported participant characteristics and inclusion of a
wide variety of characteristics (ie, participants from
adolescent through adulthood, both sexes). For example,
we identiﬁed statistical heterogeneity for PPTs, but sex
alone was not a factor that explained this ﬁnding.
Authors should continue to explore how these biopsychosocial factors inﬂuence QST to better interpret and
apply these ﬁndings. The main risk of bias across studies
was the lack of allocation concealment. Future investigators
should blind researchers to group allocation whenever
possible. Exploring treatment types that restore effective
pain modulation in patients with PFP, as well as factors
inﬂuencing QST in this population, will also be helpful.
CONCLUSIONS

Our ﬁndings support signs of central sensitization in
patients with PFP compared with pain-free control
individuals. For individuals with PFP who demonstrate
signs of central sensitization, clinicians should structure a
multimodal care plan that addresses both movement and
pain, as these factors may contribute to pain persistence.
Tracking these outcomes during rehabilitation can demonstrate restoration of effective central pain modulation,
which may be critical for long-term treatment success.
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Central sensitization mechanisms may reﬂect a subgroup
of patients with PFP. In this case, it would be important to
screen patients individually in order to select a treatment
program that accounts for central changes. In addition, QST
can be tracked over time to determine whether selected
treatment approaches effectively restore normal central
pain modulation.
A variety of QST protocols and methods can be applied
clinically. One example is handheld algometers, which are
an affordable clinical alternative to computerized algometers, although they cannot standardize the pressure
delivered over time. Similarly, PPTs can be used to
determine the magnitude of CPM. In this test, the CPM
response is calculated by comparing PPTs before and
during the application of another noxious stimulus (ie, ice
immersion of an extremity). Temporal summation can be
assessed via the change in reported pain intensity with
repetitive application of a monoﬁlament.
As our understanding of PFP evolves, the use of QST in
the clinical environment becomes more imperative. In knee
osteoarthritis (among other conditions), QST has helped to
identify dysfunctional pain processing resulting from and
contributing to pain perceptions.57 The QST responses also
predicted analgesic responses, operative and nonoperative
treatment responses in individuals with knee osteoarthritis,57 and chronic pain development.14,16,18 The outcomes of
QST can guide treatment selection among options with
known peripheral or central effects.17 Similar ﬁndings have
not yet been reported for PFP; however, our review
provides support for these endeavors.
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